Skip to main content
Clinical Trials/NCT06168565
NCT06168565
Completed
Not Applicable

Hemodynamic Effects of Intermittent Pneumatic Compression for Sports: A Double-blinded Randomized Crossover Study

University of Maia1 site in 1 country23 target enrollmentAugust 25, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sports Physical Therapy
Sponsor
University of Maia
Enrollment
23
Locations
1
Primary Endpoint
End-diastolic peak velocity
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of this randomized crossover trial is to assess the hemodynamic effects caused by the use of 2 distinct intermittent pneumatic compression protocols on athletes.

The main questions it aims to answer are:

  • Does intermittent pneumatic compression enhance athletes blood flow?
  • If yes, what pressure is better to cause this enhancement?
Registry
clinicaltrials.gov
Start Date
August 25, 2023
End Date
September 27, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Sponsor
University of Maia
Responsible Party
Principal Investigator
Principal Investigator

Filipe Silvano Pinto Maia

Principal Investigator

University of Maia

Eligibility Criteria

Inclusion Criteria

  • male gender
  • competing in soccer of track and field for at least two years
  • not have performed any physical activity on the data collection day

Exclusion Criteria

  • more than one risk factor for thromboembolism (e.g., use of tobacco, varicose veins)
  • injured athletes

Outcomes

Primary Outcomes

End-diastolic peak velocity

Time Frame: 2 minutes before the IPC protocol, during (8th minute mark - at different phases of the IPC cycle), and 2 minutes after the conclusion of the 15 minute protocol.

End-diastolic peak velocity will be assessed in a supine position on the right common femoral artery using an ultrasound (Logiq e BT12; General Electric, Fairfield, CT, USA) with a 3 to 12 MHz multi-frequency linear phase array transducer.

Systolic peak velocity

Time Frame: 2 minutes before the IPC protocol, during (8th minute mark - at different phases of the IPC cycle), and 2 minutes after the conclusion of the 15 minute protocol.

Systolic peak velocity will be assessed in a supine position on the right common femoral artery using an ultrasound (Logiq e BT12; General Electric, Fairfield, CT, USA) with a 3 to 12 MHz multi-frequency linear phase array transducer.

Arterial Diameter

Time Frame: 2 minutes before the IPC protocol, during (8th minute mark), and 2 minutes after the conclusion of the 15 minute protocol.

Assessment of arterial diameter via automatic edge detection software (FMD Studio, Pisa, Italy) measuring the distance between the near and far wall of the intima

Secondary Outcomes

  • Heart rate(2 minutes before the IPC protocol, during (8th minute mark - at different phases of the IPC cycle), and 2 minutes after the conclusion of the 15 minute protocol.)

Study Sites (1)

Loading locations...

Similar Trials